Skip to main content
Log in

Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Objectives

To assess the value of gadoxetic acid-enhanced and diffusion-weighted (DW) magnetic resonance (MR) imaging for differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas (EHEs).

Methods

We reviewed MR images of seven patients with pathologically determined hepatic angiosarcomas, 11 patients with hemangiomatosis, and five patients with EHEs. Two radiologists assessed morphologic features, signal intensity (SI), enhancement patterns, and the presence of diffusion restriction by consensus and compared between angiosarcoma vs hemangiomatosis and angiosarcoma vs EHEs.

Results

Angiosarcomas more frequently showed mixed well- and ill-defined margins (6, 85.7%), mixed strong and intermediate-high SI (5, 71.4%) on T2-weighted images, mixed peripheral and/or central nodular and rim and/or target enhancement (5, 71.4%), and mixed presence and absence of diffusion restriction (7, 100%) compared with hemangiomatosis and EHEs (P < 0.05). The overall survival rate in patients with angiosarcomas was 42.9% at 3 months and 14.3% at 14 months, whereas all patients with EHEs were alive during the follow-up period from 4 to 43 months (P = 0.002).

Conclusion

Gadoxetic acid-enhanced and DW MR imaging may help differentiate primary hepatic angiosarcomas with hemangioma-like appearance, EHE-like appearance, or both; and poor prognosis from hemangiomatosis and EHEs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

EHE:

Epithelioid hemangioendothelioma

DW:

Diffusion-weighted

MR:

Magnetic resonance

SI:

Signal intensity

CSF:

Cerebrospinal fluid

ADC:

Apparent diffusion coefficient

ROI:

Region of interest

References

  1. Mani H, Van Thiel DH. Mesenchymal tumors of the liver. Clin Liver Dis. 2001;5(1):219–57 (viii).

    Article  CAS  PubMed  Google Scholar 

  2. Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci. 2003;48(4):677–82.

    Article  PubMed  Google Scholar 

  3. Kim HR, Rha SY, Cheon SH, Roh JK, Park YN, Yoo NC. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol ESMO. 2009;20(4):780–7.

    Article  CAS  Google Scholar 

  4. Koch M, Nielsen GP, Yoon SS. Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangiopericytomas. J Surg Oncol. 2008;97(4):321–9.

    Article  PubMed  Google Scholar 

  5. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine. 1979;58(1):48–64.

    Article  CAS  PubMed  Google Scholar 

  6. Buetow PC, Buck JL, Ros PR, Goodman ZD. Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiogr Rev Publ Radiol Soc N Am Inc. 1994;14(1):153–66 (quiz 67–8).

    CAS  Google Scholar 

  7. Kim YK, Kim CS, Lee JM, Chung GH, Chon SB. Efficacy and safety of radiofrequency ablation of hepatocellular carcinoma in the hepatic dome with the CT-guided extrathoracic transhepatic approach. Eur J Radiol. 2006;60(1):100–7.

    Article  PubMed  Google Scholar 

  8. Drinkovic I, Brkljacic B. Two cases of lethal complications following ultrasound-guided percutaneous fine-needle biopsy of the liver. Cardiovasc Intervent Radiol. 1996;19(5):360–3.

    Article  CAS  PubMed  Google Scholar 

  9. Mahony B, Jeffrey RB, Federle MP. Spontaneous rupture of hepatic and splenic angiosarcoma demonstrated by CT. AJR. 1982;138(5):965–6.

    Article  CAS  PubMed  Google Scholar 

  10. Rademaker J, Widjaja A, Galanski M. Hepatic hemangiosarcoma: imaging findings and differential diagnosis. Eur Radiol. 2000;10(1):129–33.

    Article  CAS  PubMed  Google Scholar 

  11. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Tissue-specific MR contrast agents. Eur J Radiol. 2003;46(1):33–44.

    Article  PubMed  Google Scholar 

  12. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT—a multicenter trial. J Comput Assist Tomogr. 2006;30(3):345–54.

    Article  PubMed  Google Scholar 

  13. Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol. 2009;19(2):342–57.

    Article  PubMed  Google Scholar 

  14. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR. 2007;188(6):1622–35.

    Article  PubMed  Google Scholar 

  15. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (New York, NY). 2009;1(2):102–25.

    Article  Google Scholar 

  16. Danet IM, Semelka RC, Braga L, Armao D, Woosley JT. Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging. 2003;21(2):95–101.

    Article  PubMed  Google Scholar 

  17. Koyama T, Fletcher JG, Johnson CD, Kuo MS, Notohara K, Burgart LJ. Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology. 2002;222(3):667–73.

    Article  PubMed  Google Scholar 

  18. Kojiro M, Nakashima T, Ito Y, Ikezaki H, Mori T, Kido C. Thorium dioxide-related angiosarcoma of the liver. Pathomorphologic study of 29 autopsy cases. Arch Pathol Lab Med. 1985;109(9):853–7.

    CAS  PubMed  Google Scholar 

  19. Ludwig J, Hoffman HN. Hemangiosarcoma of the liver. Spectrum of morphologic changes and clinical findings. Mayo Clin Proc. 1975;50(5):255–63.

    CAS  PubMed  Google Scholar 

  20. Peterson MS, Baron RL, Rankin SC. Hepatic angiosarcoma: findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR. 2000;175(1):165–70.

    Article  CAS  PubMed  Google Scholar 

  21. White PG, Adams H, Smith PM. The computed tomographic appearances of angiosarcoma of the liver. Clin Radiol. 1993;48(5):321–5.

    Article  CAS  PubMed  Google Scholar 

  22. Lin J, Ji Y. CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma. HBPD INT. 2010;9(2):154–8.

    PubMed  Google Scholar 

  23. Chen Y, Yu RS, Qiu LL, Jiang DY, Tan YB, Fu YB. Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma. WJG. 2011;17(30):3544–53.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ. Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI. Abdom Imaging. 2013;38(4):745–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seong Hyun Kim.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seo, J.W., Kim, S.H., Kim, A.Y. et al. Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging. Jpn J Radiol 35, 655–663 (2017). https://doi.org/10.1007/s11604-017-0676-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-017-0676-1

Keywords

Navigation